Drug Retail

Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) today announced record earnings and sales for the third quarter of fiscal year 2011. Net earnings per diluted share for the quarter ended May 31 increased 38.3 percent to 65 cents, compared with 47 cents per diluted share in the year-ago quarter. This year's...

Walgreens (NYSE: WAG) today said that contract renewal negotiations with pharmacy benefit manager Express Scripts, Inc. (NASDAQ: ESRX) have been unsuccessful, and as a result the company is planning not to be part of Express Scripts' pharmacy provider network as of Jan. 1, 2012. Beginning next...

We took at look at the equity universe for stocks offering solid dividend growth prospects and the opportunity for capital appreciation this year. Here are six names we think could shoot higher.  Walgreen (WAG) operates thousands of drugstores across the United States. Just like a typical drugstore...

We took at look at the equity universe for stocks offering solid dividend growth prospects and the opportunity for capital appreciation this year. Here are six names we think could shoot higher.  Walgreen (WAG) operates thousands of drugstores across the United States. Just like a typical drugstore...

We took at look at the equity universe for stocks offering solid dividend growth prospects and the opportunity for capital appreciation this year. Here are six names we think could shoot higher.  Walgreen (WAG) operates thousands of drugstores across the United States. Just like a typical drugstore...

We took at look at the equity universe for stocks offering solid dividend growth prospects and the opportunity for capital appreciation this year. Here are six names we think could shoot higher.  Walgreen (WAG) operates thousands of drugstores across the United States. Just like a typical drugstore...

We took at look at the equity universe for stocks offering solid dividend growth prospects and the opportunity for capital appreciation this year. Here are six names we think could shoot higher.  Walgreen (WAG) operates thousands of drugstores across the United States. Just like a typical drugstore...

US stock futures are higher this morning, ahead of a confidence vote in the Greek parliament later in the day. Futures on the Dow Jones Industrial Average surged 41 points to 12,054.00 and futures on the S&P 500 stock index rose 4.90 points to 1,278.70. Nasdaq 100 futures gained 7.50 points to...

Jabil Circuit Inc (NYSE: JBL) is projected to report its FQ3 earnings at $0.57 per share on revenue of $4.14 billion. Barnes & Noble Inc (NYSE: BKS) is estimated to post a FQ4 loss at $0.91 per share on revenue of $1.39 billion. Commercial Metals Company (NYSE: CMC) is expected to report its...

Some of the stocks that may grab investor focus today are: Wall Street expects Adobe Systems Inc (NASDAQ: ADBE) to report its FQ2 earnings at $0.51 per share on revenue of $994.78 million. ADBE shares declined 1.65% to $30.44 in after-hours trading. Analysts are expecting Carnival Corp (NASDAQ:...

Brian Sozzi of Wall Street Strategies is out with a research note this morning on the potential economic fallout of a Greece default on the U.S. consumer, as well as the parallels of the situation in Greece to a couple of U.S.-based retailers. Sozzi says that enormous amounts of debt are prevalent...

Morgan Stanley is out with its report today on Walgreens (NYSE: WAG), maintaining Overweight. In a note to clients, Morgan Stanley writes, "Gross margins could be soft in the near-term, but we know gross margin dollars will be expanding starting in December as the new generics arrive, so we are...

Goldman Sachs maintains its Buy rating and its $48 price target on Walgreen Company (NYSE: WAG) as the company prepares to release its quarter results, due next Tuesday. In the report, Goldman Sachs writes, “For WAG's May quarter results, due out on June 21, we expect EPS of $0.63, vs. $0.52 a...

Citigroup has raised the price target on Walgreen (NYSE: WAG) from $43 to $48 and maintains its Hold rating.

According to J.P. Morgan, CVS Caremark (NYSE: CVS) is rated Overweight. J.P. Morgan said that, as part of CVS Caremark Week, it discusses takeaways from its conference call yesterday with Larry Merlo, CEO of CVS Caremark. “While nothing materially incremental came out of the call, we found Mr....